(Reuters) -Viking Therapeutics shares climbed 9% on Monday after the drug developer's oral obesity treatment helped reduce ...

Key efficacy and safety recommendations were as follows [104]: "...weight loss and weight maintenance should be demonstrated over the course of at least 1 year before a product can be considered ...

produces maximal weight loss in patients with obesity compared with other surgical procedures and with weight loss drugs, ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

Hair loss is a common problem in clinical dermatology, with many aetiologies including but not limited to androgenetic ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

A new report explores the consequences of losing access to glyphosate, a widely used herbicide, for U.S. agriculture and ...

Weight-loss drugs, particularly newer options like GLP-1 receptor agonists, are revolutionising the treatment of obesity and ...

Discover the best and safest weight loss supplements that support your healthy dieting and exercise routine. From fat burners ...

AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a ...